Clinical Trial Update: VAccination in Early and ADvanced Prostate caNCEr [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 vaccination trial for intermediate-risk and castration-resistant prostate cancer has been terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Oxford | Conditions: Intermediate Risk Prostate Cancer, Castration-resistant Prostate Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-06-25